Management of tricuspid regurgitation in congenital heart disease: Is survival better with valve repair?  by Said, Sameh M. et al.
C
H
D
Congenital Heart Disease Said et alManagement of tricuspid regurgitation in congenital heart disease:
Is survival better with valve repair?Sameh M. Said, MD,a Joseph A. Dearani, MD,a Harold M. Burkhart, MD,a Heidi M. Connolly, MD,b
Ben Eidem, MD,c Paul E. Stensrud, MD,d and Hartzell V. Schaff, MDaFrom th
Cardi
Disclosu
Read at
gery,
Receive
public
Address
Mayo
mayo
0022-52
Copyrig
http://dx
412Objective: Tricuspid valve (TV) regurgitation in congenital heart disease includes a heterogeneous group of
lesions, and few series have documented the outcomes.
Methods:We reviewed the records of 553 patients with congenital heart disease who had undergone TV surgery
for tricuspid regurgitation from January 1993 to December 2010. Patients with Ebstein malformation were
excluded. Their mean age was 32  21 years, and 300 were female (54%). The most common diagnoses
were conotruncal anomaly in 216 patients (39%), previous ventricular septal defect closure in 83 (15%),
atrioventricular septal defect in 77 (14%), and pulmonary atresia with an intact ventricular septum in 11
(2%). Preoperative right-sided heart failure was present in 124 patients (22%), and 55 patients (10%) had
pulmonary hypertension.
Results: TV repair was performed in 442 (80%) and TV replacement in 111 (20%) patients. Repeat sternotomy
was performed in 415 patients (75%). Previous TV repair was present in 44 patients (8%); of these, 17 (38.6%)
underwent repeat TV repair. The overall early mortality was 3.1% (17 patients) and was 2.5% for TV repair and
5.4% for TV replacement (P ¼ .001). The mean follow-up period was 4.5  4.1 years (maximum, 18). The
overall survival at 1, 5, and 10 years was 97%, 93%, and 85%, respectively. Survival was better for patients
with repair than with replacement. TV repair was an independent predictor of better survival (P ¼ .001).
Conclusions: Important tricuspid regurgitation can occur with a variety of congenital diagnoses. Early
mortality is low and late survival is superior with tricuspid repair than with valve replacement. Surgical
treatment of tricuspid regurgitation in congenital heart disease should be performed before the onset of heart
failure. (J Thorac Cardiovasc Surg 2014;147:412-9)Congenital (non-Ebstein) tricuspid regurgitation (TR) is
more common than previously thought. It occurs with a va-
riety of congenital diagnoses and requires a unique manage-
ment strategy.1 The etiologies can include congenital
tricuspid valve (TV) dysplasia, such as in cases of
pulmonary atresia with an intact ventricular septum, and
in association with other congenital heart defects, such as
atrioventricular septal defect (AVSD) or pulmonary stenosis
with ventricular septal defect (VSD), or as a result of
annular dilatation secondary to right ventricular (RV)
volume overload (eg, atrial septal defect, anomalous pulmo-
nary venous connection, or pulmonary regurgitation). Iatro-
genic TR in the congenital population can be encountered
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The Journal of Thoracic and Cardiovascular Surgimplantable cardiac defibrillator (ICD) placement (Table
1). Few data have been published that provide the outcomes
of TV surgery in the congenital population. We reviewed
our experience with TV surgery in this heterogeneous group
of patients.METHODS
The Mayo Foundation institutional review board approved the present
study, and all patients provided informed consent. From January 1993
through December 2010, 571 patients with congenital heart disease
underwent surgery for TV regurgitation. Eighteen patients were excluded
because of an inability to obtain informed consent. The records of the re-
maining 553 patients were reviewed. Patients with Ebstein malformation
(EM), a functional single ventricle, and congenitally corrected transposi-
tion of the great arteries were excluded. The mean age was 32  21 years,
and 300 patients were female (54%).
The most common congenital diagnoses were conotruncal abnormal-
ities in 216 patients (39%), previous VSD closure in 83 patients (15%),
AVSD in 77 patients (14%), pulmonary atresia (PA) with an intact septum
in 11, and TR secondary to pacemaker or ICD placement was present in 67
patients (12%). The remaining 99 patients (18%) had TR secondary to
annular dilatation fromRV volume overload, such as in a partial anomalous
pulmonary venous connection, septal defects, and coronary artery fistulas.
Preoperative congestive heart failurewas present in 124 patients (22%),
55 patients (10%) had significant pulmonary hypertension (more than one
half, systemic), and 37 (7%) had a history of endocarditis (Table 2). One
or more previous sternotomies (8) was present in 415 patients (75%).
Forty-four patients (8%) had undergone previous TV repair, and repeat
repair was achieved in 17 (39%).ery c January 2014
Abbreviations and Acronyms
AVSD ¼ atrioventricular septal defect
EM ¼ Ebstein malformation
ICD ¼ implantable cardiac defibrillator
TR ¼ tricuspid regurgitation
TV ¼ tricuspid valve
VSD ¼ ventricular septal defect
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disease. The indication for TV intervention was the presence of severe
TR with symptoms that included fatigue, decreased stamina, reduced exer-
cise tolerance, or right-sided heart failure. Other indications included
progressive RV enlargement with or without RV dysfunction or the onset
of atrial arrhythmia. Concomitant right-sided procedures included
pulmonary valve replacement (PVR) in 207 (37%) and RV–PA conduit
replacement in 37 (7%). Concomitant left-sided procedures for lesions
that were moderate to severe that were addressed at surgery included mitral
valve repair in 80 (14%), mitral valve replacement in 44 (8%), and aortic
valve replacement in 25 (5%).
Our goal was to repair the TV whenever possible. Annular dilatation
was managed primarily by annuloplasty—eccentric (inferior annulus),
pursestring DeVega from the anteroseptal to inferoseptal commissure, or
a flexible C-shaped band from the anteroseptal commissure to the coronary
sinus. When structural abnormalities were present in the leaflets or
subvalvular apparatus, we applied some of the principles of the cone
reconstruction for EM.2 This included mobilization of the leaflet tissue
and subvalvular apparatus when needed. Other modifications for TV repair
in EM included (1) approximation of the head of the mobilized ‘‘base-
intact’’ RV freewall papillarymuscle to a corresponding head of a papillary
muscle arising from the septum supporting the septal leaflet (modified
Sebening stitch); (2) distal surgical fenestrations to create autologous
neochordae when a linear attachment or tethering of the leading edge
was present in cases of TV dysplasia; (3) placement of Gore-Tex (W. L.
Gore & Associates, Flagstaff, Ariz) artificial chordae; and (4) tricuspid
leaflet augmentation with a CorMatrix membrane (Cook Biotech, West
Lafayette, Ind) or autologous pericardium to increase the leaflet height.
A C-shaped flexible annuloplasty band (anteroseptal commissure clock-
wise to the coronary sinus) was preferred when valve stenosis was not a
concern. The use of a ring was possible in many younger patients without
creating tricuspid stenosis, because the annulus was often quite dilated;
thus, the normal adult annulus size of 20 to 22 mm could be achieved in
most children older than about 10 years. When the annulus size and
potential stenosis were a concern, a limited eccentric band from the
anteroinferior commissure to the coronary sinus was used, because this
is the area of the annulus most susceptible to dilatation and the area under
the greatest tension.
TV replacement was performed in 111 patients (20%) when repair was
not feasible, particularly in adults. Our preference has been a porcine bio-
prosthesis because of its relative good durability in the tricuspid position
and the lack of a need for chronic anticoagulation. In the present study,
92 patients (83%) underwent bioprosthetic TV replacement, and 19 pa-
tients (17%) received a mechanical prosthesis. Mechanical prostheses
were used when the RV function was good and the patient had another
need for chronic warfarin anticoagulation (eg, left-sided mechanical pros-
thesis). The technique of prosthesis placement included retaining the
tricuspid leaflet and subvalvular apparatus whenever possible. Prosthesis
suture placement was in the native leaflet tissue to minimize injury to the
conduction tissue and right coronary artery. When the leaflet tissue was
thickened and dysplastic and required resection, a rim of leaflet tissue adja-
cent to the annulus was preserved to facilitate valve suture placement. In
contrast to TV replacement for EM, the coronary sinus was always leftThe Journal of Thoracic and Cadraining into the right atrium, because the prosthesis was anchored in the
atrioventricular groove into native tricuspid leaflet tissue. In the setting
of TV leaflet regurgitation secondary to pacemaker or ICD leads, TV
replacement was performed as described, and the ventricular lead was pre-
served (when the thresholds were excellent) and positioned lateral to the
sewing ring of the prosthesis. This technique involved folding the leaflet
and annulus tissue in the area of the lead (the inferoseptal commissure
was the most common) and then placing valve sutures. This enabled the
lead to move freely outside the sewing ring of the valve. When pacemaker
lead malfunction occurred, the ventricular lead was removed, and an
epicardial system was placed at TV surgery.
The medical records were reviewed to obtain the demographic
characteristics, associated medical conditions, details of the operations,
and results of the hemodynamic and echocardiographic testing.
Statistical Analysis
The descriptive statistics for categorical variables are reported as the
frequency and percentage. Continuous variables are reported as the
mean  standard deviation or median and range, as appropriate. Contin-
uous variables were compared using the 2-sample t test or the Wilcoxon
rank sum test, as appropriate. The Kaplan-Meier method was used to
draw survival curves and calculate survival statistics at 1, 5, 10, and 15
years. Univariate and multivariate Cox regression models were used to
identify the factors associated with overall death. All the tests were
2-sided.P<.05 was considered statistically significant. Statistical Analysis
Systems, version 9.13, software (SAS Institute, Cary, NC) was used for
statistical analysis.
RESULTS
Of the 553 patients, TV repairwas performed in 442 (80%)
and valve replacement in 111 (20%). The overall early
mortality was 3.1% (17 patients). Earlymortality was greater
after TV replacement (6 patients, 5.4%) than after TV repair
(11 patients, 2.5%;P¼ .001). In the 448 patientswho had un-
dergone3 sternotomies, 82% underwent TV repair. Of the
105 patients who had undergone 4 sternotomies, 35%
required TV replacement. Delayed sternal closure was per-
formed in 35patients (6%).No risk factors for earlymortality
were identified. Early postoperative morbidity included
mechanical ventilation>5 days (n ¼ 27; 5%), permanent
pacemaker placement (n ¼ 23; 4%), renal failure (n ¼ 20;
4%), stroke (n¼ 8; 1%), and sternal infection (n¼ 6; 1%).
The mean follow-up period was 4.5  4.1 years
(maximum, 18). The univariate and multivariate risk factors
for late survival are listed in Tables 3 and 4, respectively.
Overall survival at 1, 5, and 10 years was 97%, 93%, and
85%, respectively (Figure 1, A). Survival was significantly
better for the patients with TV repair than for those with TV
replacement (P < .0001; Figure 1, B). The 1-, 5-, and
10-year survival for TV repair was 98%, 96%, and 89%
and for replacement was 91%, 81%, and 72%, respec-
tively. No significant difference was found in survival
between those who had received a bioprosthetic versus
mechanical valve (P ¼ .77; Figure 2).
DISCUSSION
Congenital (non-EM) TV regurgitation includes a wide
variety of structural lesions that can include TV dysplasia,rdiovascular Surgery c Volume 147, Number 1 413
TABLE 1. Etiologies of congenital (non-Ebstein) tricuspid regurgitation
Primary TV abnormalities (TV dysplasia)
TV dysplasia in pulmonary atresia with intact septum
Congenitally unguarded TV
Uhl’s anomaly
Secondary TV abnormalities
Atrioventricular septal defect
Right ventricular outflow tract obstructive lesions
Tetralogy of Fallot
Pulmonary atresia with ventricular septal defect
Pulmonary stenosis with ventricular septal defect
Tricuspid regurgitation with ventricular septal defect
Gerbode defect
Tricuspid annular dilatation (volume overload)
Coronary artery fistulas
Atrial/ventricular septal defect
Partial anomalous pulmonary venous connection
Iatrogenic TR
Previous ventricular septal defect closure (with or without leaflet
detachment)
Pacemaker/cardioverter defibrillator lead
TV, Tricuspid valve; TR, tricuspid regurgitation.
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with an intact ventricular septum), leaflet distortion
secondary to an unclosed VSD, or chordal disruption
secondary to previous VSD closure. TR due to annular
dilatation can also be found with congenital abnormalities
associated with RV volume overload, such as in partial
anomalous pulmonary venous connection, atrial septal
defect, pulmonary regurgitation, and coronary artery fis-
tulas or RVoutflow tract obstruction resulting in an elevated
RV pressure.3 Finally, with the increasing need for eitherTABLE 2. Baseline characteristics of study population
Characteristic All patients (n ¼ 553) T
Age (y) 32  21
Male gender 253 (46)
Era of surgery
1993-1995 29 (5)
1995-2010 524 (95)
NYHA class
II 429 (78)
III or IV 124 (22)
History of endocarditis 37 (7)
Resternotomy 415 (75)
Previous palliation 121 (22)
Diagnosis
Conotruncal anomalies 216 (39)
AVSD 77 (14)
PA/IVS 11 (2)
Annular dilatation 99 (18)
Previous VSD repair 83 (15)
Lead-induced 67 (12)
Data presented as mean standard deviation or n (%). TVR, Tricuspid valve replacement; T
defect; PA/IVS, pulmonary atresia with intact interventricular septum; VSD, ventricular se
414 The Journal of Thoracic and Cardiovascular Surgpermanent pacing or ICD placement in the congenital pop-
ulation during late follow-up, severe TR can occur; this has
often been referred to as ‘‘lead-induced’’ TR.
Increasing evidence from acquired heart failure studies
has shown that severe TR results in reduced late survival
and is associated with the onset of symptoms, atrial fibrilla-
tion, and heart failure.4,5 Consequently, an increased
awareness of the potential detrimental effect of significant
TR in the congenital heart population is essential for
clinicians caring for these patients.
In our practice, the indications for TV surgery include
symptoms (eg, fatigue, shortness of breath, edema, heart
failure; failure to thrive in an infant or child), decreased
exercise tolerance, a structural valve abnormality (eg,
ruptured chordae, leaflet defect), progressive RV dilatation,
and the onset or progression of atrial tachyarrhythmia.
Surgery should be advised before the onset of significant
RV dysfunction. Finally, we would recommend earlier
surgery if the valve anatomy is favorable for a good TV
repair. In the setting of severe pulmonary regurgitation,
we have used the development or progression of TR related
to annular dilatation as an indication for PVR, in addition to
increased RV dimensions. In addition to PVR, we repair the
TV when TR is severe or when it is moderate with severe
annular dilatation on the preoperative echocardiogram.
Importantly, the decision to repair the TV should be
made preoperatively, because the conditions of anesthesia
generally reduce the TR by at least 1 grade.
There are 2 categories of TV dysplasia, 1 with displace-
ment, which is associated with EM, and 1 without displace-
ment. TV dysplasia includes leaflet and/or subvalvular
apparatus thickening or tethering.6 Similarly, significantVR (n ¼ 111) TV repair (n ¼ 442) P value
40  20 29  20 <.001
56 (50) 197 (45) .27
.18
3 (3) 26 (6)
108 (97) 416 (94)
.005
75 (68) 354 (80)
36 (32) 88 (20)
8 (7) 29 (7) .81
96 (87) 319 (71) <.001
30 (27) 91 (21) .14
28 (25) 188 (43) .12
11 (10) 66 (15) .19
5 (5) 6 (1) .03
43 (39) 56 (13) .06
32 (29) 51 (12) .95
36 (32) 31 (7) <.001
V, tricuspid valve;NYHA,New York Heart Association; AVSD, atrioventricular septal
ptal defect.
ery c January 2014
TABLE 3. Univariate hazard ratios for late death for all patients
(n ¼ 536)
Variable HR 95% CI P value
Resternotomy 6.7 2.04-22.1 .002
Preoperative heart failure 3.6 2.04-6.33 <.001
Previous endocarditis 2.1 0.91-5.05 .08
Previous palliation 2.1 1.19-3.77 .01
Era of surgery 1.3 0.58-3.07 .49
Older age 1 1.01-1.04 <.001
Etiology of tricuspid regurgitation 0.9 0.25-3.18 .86
Gender 0.7 0.37-1.18 .1
Tricuspid valve repair 0.3 0.14-0.44 <.001
HR, Hazard ratio; CI, confidence interval.
FIGURE 1. Kaplan-Meier graphs showing (A) the overall survival of
patients after tricuspid valve surgery, and (B) survival difference between
tricuspid valve repair and replacement groups. TVR, Tricuspid valve
replacement; TV, tricuspid valve.
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cular septum. In contrast to the other conotruncal anomalies
(transposition of the great arteries, tetralogy of Fallot,
truncus), the TV is abnormal from the beginning and might
require surgical intervention early in life. In addition,
reoperation for recurrent TR is more common in the
presence of TV dysplasia and PA with an intact septum.
Other diagnoses that can result in TR secondary to a
structural abnormality include AVSD and chordal disrup-
tion after VSD closure. TR can also be encountered
with VSD from other mechanisms: (1) leaflet deformity,
(2) TV overriding or straddling, (3) abnormal chordal at-
tachments, (4) Gerbode defect,7 and (6) leaflet distortion
secondary to VSD patch closure with or without TV leaflet
detachment. TVanterior and or septal leaflet detachment is
sometimes needed to facilitate VSD closure, which serves
to decrease the risk of residual shunt or heart block. The
potential disadvantage with this technique is TV leaflet
distortion and secondary regurgitation. In the series
reported by Bol-Raap and colleagues,8 188 patients under-
went VSD closure from 1992 to 2001. Temporary detach-
ment of the TV was performed in 46 patients (24%).
Trivial TR was present in 10 patients (22%) postoperatively
among the detachment group and in 57 patients from the
nondetachment group (40%). No patients required reoper-
ation for TV dysfunction during a mean follow-up period
of 2.6 years.8 Tatebe and colleagues9 recommended
avoidance of TV detachment in small infants and those
with Down syndrome because of the high incidence of TR.
TV regurgitation can also occur from annular dilatation.
This can occur with a left-to-right shunt, such as is seen withTABLE 4. Multivariate hazard ratios for late death for all patients
(n ¼ 536)
Variable HR 95% CI P value
Resternotomy 12 3.24-41.31 <.001
Preoperative heart failure 3.3 1.82-6.12 <.001
Previous palliation 2.2 1.2-3.96 .009
Older age 1 1.01-1.04 .003
Tricuspid repair 0.4 0.19-0.65 .001
HR, Hazard ratio; CI, confidence interval.
The Journal of Thoracic and Caan atrial septal defect or partial anomalous pulmonary
venous connection, from RV dilatation secondary to
pulmonary regurgitation, or from increased RV pressure
secondary to RV outflow tract obstruction.5 Concomitant
TV repair at PVR is still controversial, because the
long-term effects of PVR on the RV size and secondary
TR is unclear. Kogon and colleagues10 reported theFIGURE 2. Kaplan-Meier graphs showing late survival of patients after
tricuspid valve replacement with mechanical versus biologic valves.
rdiovascular Surgery c Volume 147, Number 1 415
FIGURE 3. A and B, Pathologic specimens and (C) intraoperative photograph showing perforation or entanglement of the tricuspid valve leaflet with
pacemaker or cardioverter-defibrillators lead (arrows). Reprinted with permission.1
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repair of tetralogy of Fallot or congenital pulmonary
stenosis from 2002 to 2008. These patients had had at
least moderate TR at PVR; however, the degree of TR
and RV dilatation had decreased significantly at 1 month
postoperatively, with no additional improvement seen at
late follow-up.10
Atrial and ventricular arrhythmias are a frequent late
complication in congenital heart disease, and the need for
a pacemaker or ICD has been increasing. We identified 67
patients (12%) who had undergone surgical intervention
for ‘‘lead-induced’’ TR. The following mechanisms of TR
were identified: (1) leaflet perforation, (2) lead entangle-
ment of the TV apparatus, (3) lead impingement of the
TV leaflets, and (4) lead adherence to the TV (Figure 3).
TV replacement was required in 38 patients (56%), and
repair was possible in 29 (44%).
In general, the approach to TV repair in patients with a
structural abnormality of the valve often requires attention
to the abnormality of the subvalvular apparatus or the
leaflet. Specifically, annuloplasty techniques alone are
usually inadequate to obtain a durable result when the
mechanism is a structural abnormality and not annular
dilatation. The recent application of the cone technique
and its modifications for EM2,11 can be helpful in
optimizing successful TV repair in the presence of
structural abnormalities. This can include resection of
dysplastic leaflet tissue, approximation of leaflet defects
or zones of apposition, placement of artificial Gore-Tex
(W. L. Gore) chordae, leaflet augmentation for deficient
leaflets, papillary muscle head approximation, leaflet edge
incisions to create neochordae, and so on. The addition of
an annuloplasty band is important to stabilize the repair
that might have included 1 of these techniques. Repair
techniques in the presence of a permanent pacemaker or
ICD lead vary and will depend on the degree of damage
to the TV leaflets. However, they can include 1 of the416 The Journal of Thoracic and Cardiovascular Surgfollowing: (1) moving the lead away from the damaged
leaflet, (2) suture repair of the leaflet defect, and (3) reposi-
tioning the lead by suture fixation at either the inferoseptal
or anteroinferior commissure. Ringed annuloplasty is also
usually performed (Figure 4).
Raikhelkar and colleagues12 reported the outcome of TV
repair versus replacement in 56 consecutive adult patients
undergoing isolated TV surgery from 1998 to 2010
(9 patients had congenital TR). No difference was found
in survival between repair and replacement, but the
investigators recommended timely referral to surgery
before the onset of heart failure. In the report by Chen
and colleagues,13 77 patients underwent repeat sternotomy
for TV surgery from 2005 to 2010. TV repair was possible
in 44 patients (57%). Compared with the repair group,
greater morbidity and reduced late survival were found in
the replacement group, and these investigators also
recommended earlier intervention before the onset of
decompensated heart failure.13
TV repair versus replacement has not been previously
studied in patients with congenital heart disease owing to
the heterogeneity of TR in this population. In the present
study, valve replacement was more likely and occurred in
35% of the patient population if there were 4 previous
sternotomies compared with 20% if they had undergone
3 previous sternotomies. The multivariate analysis in
our study demonstrated improved late survival with TV
repair compared with TV replacement (Figure 1, B). How-
ever, late reoperation for recurrent TR was a significant risk
factor for late mortality, emphasizing the importance of ob-
taining a good to excellent result with TV repair—ideally
striving for mild or less regurgitation on the intraoperative
transthoracic echocardiogram. Our approach in children is
to accept moderate or less regurgitation intraoperatively;
however, we counsel the patient and family that reoperation
for progressive TR is more likely. In the adult age
group, we are less likely to accept moderate or more TRery c January 2014
FIGURE 4. A-C, In the presence of pacemaker or cardioverter defibrillator leads, repair techniques vary and depend on the degree of damage of leaflets. In
the absence of extensive leaflet damage, valve repair is preferred. It usually involves removing (incising) the lead away from the damaged leaflet, and suture
repair of the leaflet defect if present and repositioning the lead by suture fixation against the annulus. Most often suture fixation is in the recess of either the
inferoseptal or anteroinferior commissure. Finally, ringed annuloplasty is performed. Reprinted with permission.1
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particularly when the patient has already had multiple
previous operations, because we have previously shown a
significant increase in early and late mortality at sternotomy
number 5 and beyond.14,15
CONCLUSIONS
Important TR can occur with a variety of congenital
diagnoses. Early mortality has been low and late survival
is superior with tricuspid repair compared with TV
replacement. Surgical treatment of TR in patients with
congenital heart disease should be performed before the
onset of heart failure.
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Dr Charles D. Fraser (Houston, Tex). I have no disclosures.
I congratulate Dr Said. I have heard him present before, and this
is another example of a beautifully presented paper and elegant
slides and very clear, and I thank you for that.rdiovascular Surgery c Volume 147, Number 1 417
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DYou and your colleagues from the Mayo Clinic have conducted
yet another elegant study and presentation, and all of us who
practice congenital heart surgery owe a debt of gratitude to the
Mayo surgical legacy of innovation and scholarly assessment of
results that was emphasized so nicely by our current president,
Dr Schaff, in his presentation earlier today.
This very large retrospective review of 553 patients with
congenital heart disease and associated TV corrective surgery
provides a window of opportunity for our understanding of the
results after TV operations in an admittedly very heterogeneous
population of patients, as you noted in your presentation and
report.
The central question of focus in all of our minds I expect is
‘‘What are we to do with this information in modifying our
approach to the TV in patients with congenital heart disease?’’
As such, I ask the following questions, and I will ask them in series,
and you can just answer them before going to the next.
The first, in your analysis of the predictors of mortality, you
found TV replacement, repeat sternotomy, previous palliation,
and older age to be risk factors. Given that, with the exception
of valve replacement, this accounts for almost everyonewhomight
ultimately need TV surgery after previous congenital heart
surgery. How are we to use these data in decision-making about
who needs TV surgery?
Dr Said. Thank you, Dr Fraser, for your comments.
First, regarding the predictors of mortality. The message from
this report, despite this heterogeneous group, is we should operate
earlier when significant TR is present and not consider it as a
benign lesion. Heart failure and resternotomy are also predictors
of mortality. Valve repair is almost always preferred, but when
we cannot achieve a successful repair of moderate or less regurgi-
tation, it is reasonable to consider TV replacement, because it
treats right-sided heart failure and might delay the next sternotomy
compared with a poor tricuspid valve repair.
Dr Fraser. Sort of as an extension of that question, and I had the
opportunity to review the report, and I realize you cannot share all
that information in a brief presentation such as this, but in the
report, you noted that your indication for surgery on a TV was
moderate or more TR. However, you also noted that you and others
have clearly shown that, for example, in a patient with late repaired
tetralogy of Fallot who had severe pulmonary valve insufficiency
and a dilating right ventricle, if you placed a competent pulmonary
valve, the TV would get better.
Thus, from this study and your own experience, how did these
data change your thinking and what are your current indications
for intervention on the TV?
Dr Said. In general, the current indication for TV intervention is
the presence of severe TR and symptoms, which can include right-
sided heart failure, decreased exercise tolerance, and/or fatigue.
When TR is secondary, for example, in the setting of pulmonary
regurgitation, we intervene on the TV when grade III or IV TR
is present, a structural abnormality is present with the valve (eg,
chordal rupture or leaflet defect), when severe annular dilatation
is present, or when the pulmonary artery pressures are elevated.
In patients who are apparently asymptomatic, we perform exercise
testing. If the test results are abnormal, we would lean toward TV
repair. When the exercise testing results are normal, we monitor
the RV size with serial imaging, magnetic resonance imaging418 The Journal of Thoracic and Cardiovascular Surgmost commonly. In general, the overall message is earlier inter-
vention for TR.
Dr Fraser. Just to follow up on the indications a bit. Would you
suggest the addition of more objective measures such as stress
testing or magnetic resonance imaging evaluation of the right
ventricle as additional adjuncts to the decision tree?
Dr Said. Yes, we believe magnetic resonance imaging is the
most valuable imaging study, because it provides an accurate
assessment of RV size and function. We find echocardiography
to be most helpful for analysis of the valve anatomy.
Dr Fraser. Finally, is the title a bit misleading? Can we, from
these data in a retrospective analysis, really conclude that it is
the operation that is the difference or is it the patients who undergo
the operation? In other words, is it justified to state that the TV
repair is protective over TV replacement or is it the patients who
require the replacement who are at higher risk, not the operation?
Dr Said. This is another important point. The clinical status of
the patients undergoing surgery, particularly those with right-sided
heart failure, also affects the outcome of reoperation. The pub-
lished data and our study have demonstrated that when surgery
is performed in the setting of class IV heart failure, early mortality
is increased and late survival is reduced. The challenge with this
study is that we had a heterogeneous group of lesions, making it
more difficult to differentiate the outcomes on the basis of repair
versus replacement alone.
Dr Fraser. Again, thank you for a very nice presentation.
Dr Christopher A. Caldarone (Toronto, Ontario, Canada).
May I extend that question just a little bit. You identify congestive
heart failure as 1 of the most important risk factors for death. It is a
modifiable risk factor. Thus, how do you use this information from
2 directions: (1) when a patient presents with congestive heart fail-
ure, do you modify the preoperative management in accordance
with this finding before you bring them to the operating room;
and (2) what patients have too much congestive heart failure to un-
dergo surgery? Are there any patients you would not operate on
and what parameters would you use to exclude a patient from
surgery?
Dr Said.Modifying heart failure before surgery will depend on
the urgency of the situation. Most patients can be medically
optimized as an outpatient. Some patients might be admitted pre-
operatively for medical refinement, including aggressive diuresis
and fluid restriction and, rarely, intravenous inotropic support.
DrCaldarone.Thus, it might be possible through an analysis of
your database to identify when you actually mitigated the effect of
congestive heart failure by those patients who were treated
preoperatively in the aggressive fashion you described?
Dr Said. Yes.
Dr Caldarone. What about patients you had excluded from
surgery, does that ever happen?
Dr Said. Patients who might not be suitable for surgery include
those with significant left ventricular dysfunction, severe RV
dysfunction, and those with liver dysfunction. In general, if the
synthetic function of the liver is intact, we offer surgery. Young
patients with severe biventricular dysfunction or multiple organ
system dysfunction usually undergo evaluation for potential
multiple organ transplantation.
Dr Christopher Baird (Boston, Mass). With regard to the
variables of reoperative TV repair in resternotomy, it seems thatery c January 2014
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Dyou have identified at least resternotomy as a risk factor. With your
large database, were you able to identify how this might guide your
ability to decide whether to repair the valve again or replace the
valve?
Dr Said. Some situations might allow valve repeat repair. In
general, if the leaflet tissue and subvalvular apparatus are pliable
and thin, we attempt repeat repair. The various techniques for
repair of the Ebstein TV can be applied and can help facilitate
valve repair. As the tricuspid leaflet tissue becomes thicker and
more rigid, repeat repair becomes more difficult and replacement
more likely. We have previously published information related to
the sternotomy number and operative risk. The operative risk
increases at the fourth and fifth sternotomy. Consequently, the
sternotomy number also affects the decision to replace versus
repeat repair. We are more likely to replace the TV at the fourth
or fifth redo unless it is a straightforward TV repair with a high
probability of good valve competence.
Dr Pedro J. del Nido (Boston, Mass). Can I follow up on the
issues of functional TR. Can you give us a bit more information
on the patient groups, how many of these patients had left–sided
disease at the same time you were treating the TV and was that
taken into consideration as 1 of the risk factors?
Dr Said. In general, the left ventricular function was normal
for most patients. Approximately 30% of patients underwent a
left-sided procedure; mitral valve surgery was most common.
Importantly, however, this study focused on patients whose main
problem was TR. Specifically, this was their main hemodynamic
lesion and the main indication for surgery. Left-sided lesions,
when present, were usually of moderate severity (eg, moderate
mitral regurgitation) and were addressed during surgery but were
not the main indications for surgery.
Dr del Nido. Because 1 of the points that is well documented
now in adult published studies is functional TR in the face of
mitral disease and that mortality is significantly greater if you
do not address it at the same time as the mitral valve. I am
wondering whether you included the functional TR patients into
a congestive heart failure category. How many of those
patients actually had also either left atrioventricular valve orThe Journal of Thoracic and Casome sort of left-sided heart disease as a part of their congestive
heart failure?
Dr Said. I think that would be about 25% or 30% of these
patients also had left-sided problems. A mitral valve procedure
was performed in 23% and an aortic valve procedure in 9%. In
general, these left-sided lesions were not severe but were abnormal
enough that an intervention was performed because surgery was
advised for right-sided heart failure. It is reasonable to assume
that patients with severe left-sided abnormalities that are corrected
(eg, severe aortic stenosis or severe mitral regurgitation) will result
in some improvement in functional TR.
Dr del Nido. Thus, I guess the next question would be ‘‘If you
have a patient who you are operating on for the left–sided
atrioventricular valve, let us say a canal, who has moderate TR,
they have symptoms, that is why you are operating on the left
side, what would be your decision tree as far as whether to
intervene on the right side as well?
Dr Said. If severe TR is present or the TV has any structural
abnormalities on preoperative imaging or intraoperative transeso-
phageal echocardiography, we repair the TV. If the TR is
moderate and no tricuspid structural abnormality is present and a
severe left-sided lesion is also present that is being fixed, we
usually leave the TV alone.
Dr del Nido. Although many times the problem is not so much
annular, I mean there are subvalvular problems in these patients,
some of the subvalvular apparatus is quite abnormal. In your
images, or at least in the schematics you showed, it seems as if
most of the work that you are focusing on is annuloplasty and
some commissuroplasty. Is there any work that is also done in
the subvalvular apparatus?
Dr Said. Repair maneuvers are directed at the abnormality. In
most situations in this patient cohort, this was at the leaflet or
annular level. The subvalvular apparatus was addressed when a
problem was identified in this area—unsupported segments might
be treated with artificial chordae, mobilization of papillary
muscles, approximation of1 of the papillary muscles to the ven-
tricular septum, or creation of autologous chordae for the tethered
leading edge are some examples of subvalvular maneuvers.rdiovascular Surgery c Volume 147, Number 1 419
